Preclinical data for CLYM116, anti-APRIL monoclonal antibody, highlight favorable pharmacokinetic and pharmacodynamic profile ...

Upstream Bio, Inc. presented data at the European Academy of Allergy & Clinical Immunology Congress highlighting the advantages of verekitug, a treatment targeting the TSLP receptor, over tezepelumab, ...

Upstream Bio Inc. (NASDAQ:UPB) is one of the best hot stocks to invest in. On September 30, Upstream Bio presented new ...

Climb Bio (CLYM) announced the upcoming presentation of CLYM116 preclinical data and published budoprutug pMN Phase 1b long-term outcome data at the 2025 American Society of Nephrology Kidney Week, ...

HENDERSON, Nev.--(BUSINESS WIRE)--Zura Bio Limited (Nasdaq: ZURA) (“Zura Bio”), a clinical-stage immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases, ...

Enterprise platform, queried through natural language, to help pharma, biotech, and investors make better decisions.

CellCodex has been established by an experienced team with a mission to provide better biological data to train advanced ...

Biomedical Artificial Intelligence and Computational Modeling are new emerging areas in biomedical engineering. These areas cover: Data analysis and interpretation: developing and applying algorithms ...

Holiverse, a leading health technology company, has officially launched a groundbreaking bio-database platform that allows individuals to take control of their personal health data and monetise it.